Brief: Newron Pharmaceuticals H1 net result swings to profit of EUR 1.5 mln
Sept 14 (Reuters) - NEWRON PHARMACEUTICALS SPA NWRN.S :
* H1 NET PROFIT OF EUR 1.5 MILLION, COMPARED TO A LOSS OF EUR 8.8 MILLION IN SAME PERIOD IN
2016
* H1 REVENUES EUR 11.7 MILLION VERSUS EUR 3.9 MILLION IN HY1 2016
* H1 CASH USED IN OPERATING ACTIVITIES HAS BEEN REDUCED FROM EUR 8.9 MILLION IN HY1 2016 TO
EUR 1.5 MILLION THIS YEAR
Source text for Eikon: ID:nTENf6ilma
Further company coverage: NWRN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study